Insider trading · Q3 2026 · CIK 1682852

Moderna, Inc. (MRNA) insider trading.

In Q3 2026, insiders at Moderna, Inc. reported 42 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 10 sales worth $49.2M.

Transactions
42
Purchases (P)
0
Sales (S)
10
Net shares, P minus S
-671,464
Insiders
4
Last filed
2026-09-16

Insiders

InsiderRelationshipTransactionsBuysSales
Hoge StephenOfficer · President1303
Mock James MOfficer · Chief Financial Officer1302
Klinger Shannon ThymeOfficer · Chief Legal Officer1001
Bancel StephaneDirector, Officer · Chief Executive Officer604

Transactions

42 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-15Hoge StephenS (D)40,281$146.071,562,029Form 4
2026-09-15Hoge StephenM (A)76,452$12.211,602,310Form 4
2026-09-14Hoge StephenS (D)40,294$144.131,525,858Form 4
2026-09-14Hoge StephenM (A)76,453$12.211,566,152Form 4
2026-09-10Mock James MM (A)19,836$30.9694,211Form 4
2026-09-10Mock James MS (D)15,000$134.4959,375Form 4
2026-09-10Mock James MS (D)19,836$134.4974,375Form 4
2026-09-04Klinger Shannon ThymeF (D)5,704$148.8781,340Form 4
2026-09-04Klinger Shannon ThymeM (A)11,797—87,044Form 4
2026-09-04Mock James MM (A)11,797—80,079Form 4
2026-09-04Mock James MF (D)5,704$148.8774,375Form 4
2026-09-01Hoge StephenM (A)9,283—1,494,188Form 4
2026-09-01Hoge StephenF (D)4,489$140.341,489,699Form 4
2026-09-01Mock James MM (A)2,475—69,479Form 4
2026-09-01Mock James MF (D)1,197$140.3468,282Form 4
2026-09-01Klinger Shannon ThymeM (A)2,166—76,295Form 4
2026-09-01Klinger Shannon ThymeF (D)1,048$140.3475,247Form 4
2026-09-01Klinger Shannon ThymeM (A)3,471$30.9677,600Form 4
2026-09-01Klinger Shannon ThymeS (D)3,471$139.9574,129Form 4
2026-08-28Mock James MF (D)160$142.7767,004Form 4
2026-08-28Mock James MM (A)329—67,164Form 4
2026-08-28Klinger Shannon ThymeF (D)160$142.7774,129Form 4
2026-08-28Klinger Shannon ThymeM (A)329—74,289Form 4
2026-08-28Hoge StephenM (A)611—1,485,201Form 4
2026-08-28Hoge StephenF (D)296$142.771,484,905Form 4
2026-08-27Mock James MF (D)375$149.6666,835Form 4
2026-08-27Mock James MM (A)774—67,210Form 4
2026-08-27Klinger Shannon ThymeF (D)375$149.6673,960Form 4
2026-08-27Klinger Shannon ThymeM (A)774—74,335Form 4
2026-08-27Hoge StephenM (A)1,437—1,485,285Form 4
2026-08-27Hoge StephenF (D)695$149.661,484,590Form 4
2026-08-06Bancel StephaneM (A)252,469$19.156,440,260Form 4
2026-08-05Bancel StephaneS (D)124,838$56.966,414,726Form 4
2026-08-05Bancel StephaneS (D)187,044$58.796,187,791Form 4
2026-08-05Bancel StephaneS (D)147,473$56.216,539,564Form 4
2026-08-05Bancel StephaneM (A)499,246$19.156,687,037Form 4
2026-08-05Bancel StephaneS (D)39,891$58.126,374,835Form 4
2026-07-15Hoge StephenM (A)37,226$19.151,521,074Form 4
2026-07-15Hoge StephenS (D)53,336$67.61,483,848Form 4
2026-07-15Hoge StephenM (A)16,110$19.151,537,184Form 4
2026-07-02Mock James MM (A)1,452—67,139Form 4
2026-07-02Mock James MF (D)703$72.566,436Form 4

Transaction codes in this quarter

Get MRNA insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1682852&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · MRNA company page · Moderna, Inc. on SEC.gov

Questions

Are insiders buying or selling Moderna, Inc. (MRNA)?

In Q3 2026, insiders at Moderna, Inc. reported 42 non-derivative transactions on 16 Forms 3, 4 and 5: 0 open-market purchases and 10 sales worth $49.2M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Moderna, Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/mrna.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.